Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference9 articles.
1. Clinical and Laboratory Standards Institute. CLSI M100-S20 (2010) cephalosporin and aztreonam breakpoint revisions fact sheet. Vol. 20. 2010. p. 1–10.
2. Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for enterobacteriaceae and pseudomonas aeruginosa: I. Cephalosporins and aztreonam;Dudley;Clin Infect Dis,2013
3. Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?;Livermore;J Antimicrob Chemother,2012
4. Impact of CLSI breakpoint changes on microbiology laboratories and antimicrobial stewardship programs;Heil;J Clin Microbiol,2016
5. The Clinical and Laboratory Standards Institute. M100S performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne, PA. 2016.